Literature DB >> 26112125

Retrospective review of administration of childhood primary vaccination schedule in an Irish tertiary neonatal intensive care unit.

P McCrossan1, C McCafferty2, C Murphy2, J Murphy2.   

Abstract

AIMS: Quantify and evaluate administration of the routine childhood primary vaccination schedule in a tertiary neonatal intensive care unit (NICU). STUDY
DESIGN: Retrospective review of paper record of vaccinations administered to inpatients in the NICU from 01/01/2001-30/11/2013.
METHODS: Data were extracted from hospital records and institutional databases and analysed using SPSS for Mac version 21. Analysis was made based on gestational age, chronological age at time of administration of vaccine, corrected gestational age at time of vaccine administration and type of vaccine received.
RESULTS: For all preterm (gestation < 37 weeks) babies that received the first '6in1' vaccination while an inpatient (n = 344): mean gestational age = 27.3 weeks (sd = 2.6 weeks); mean chronological age at time of vaccination = 9.4 weeks. For all preterm patients that received the second '6in1' vaccination while an inpatient (n = 19): mean gestational age = 25.6 weeks (sd = 1.63); mean chronological age at time of vaccination = 18.4 weeks. For all term (gestation ≥ 37 weeks) patients that received the first '6in1' vaccination while an inpatient (n = 9): mean gestational age = 40.1 weeks (sd = 1.9); mean chronological age at time of vaccination = 9.8 weeks. There were no reported adverse events to any of the vaccinations administered.
CONCLUSION: It is safe for premature infants to receive the routine vaccination schedule in a NICU setting.
Copyright © 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neonatal; Premature; Preterm; Vaccination

Mesh:

Year:  2015        PMID: 26112125     DOI: 10.1016/j.puhe.2015.05.005

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  3 in total

1.  Vaccination timeliness and completeness among preterm and low birthweight infants: a national cohort study.

Authors:  Dov Bary-Weisberg; Chen Stein-Zamir
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

Review 2.  Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of Neonatology.

Authors:  E Chiappini; C Petrolini; C Caffarelli; M Calvani; F Cardinale; M Duse; A Licari; S Manti; A Martelli; D Minasi; M Miraglia Del Giudice; G B Pajno; C Pietrasanta; L Pugni; M A Tosca; F Mosca; G L Marseglia
Journal:  Ital J Pediatr       Date:  2019-11-19       Impact factor: 2.638

3.  Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants.

Authors:  Marissa B Wilck; Z Jin Xu; Jon E Stek; Andrew W Lee
Journal:  Hum Vaccin Immunother       Date:  2020-08-04       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.